Strains of enterococci isolated from 34 patients were studied for susceptibility to oxacillin and gentamicin alone and in combination. The minimal bactericidal concentrations of oxacillin and gentamicin for these strains ranged from 16 to 250 jig/ml (median 32 ,ug/ml) for oxacillin and 12 to 48 ,ug/ml (median 24 ,ug/ml) for gentamicin. The minimal bactericidal concentration of oxacillin for 50% of strains in the presence of 12, 6, 3, and 1.5 ,ug of gentamicin per ml, respectively, was 2, 8, 16, and 32 ,ug/ml. The combination of oxacillin and gentamicin at clinically attainable serum levels was synergistically bactericidal against 27/34 (80%) of these strains using strict criteria. This report reconfirms the original observation that antibiotics which affect the synthesis of bacterial cell walls combine synergistically with aminoglycosides against enterococci. This is so even though enterococci are far more resistant to oxacillin than to penicillin or ampicillin. In addition, this report suggests that the combination of oxacillin and gentamicin administered in the usual dosages includes enterococci in its bactericidal spectrum.
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There have been a number of reports in recent years on the in vitro effectiveness ofpenicillin and its derivatives combined with aminoglycosides against enterococci. It has been shown that a synergistic effect is achieved when the enterococcal strain is relatively susceptible to the aminoglycoside in the combination (10). Since some strains are highly resistant to streptomycin and kanamycin, combinations of these aminoglycosides with penicillin are not synergistic against all enterococci (12, 16). No strains have been reported to be highly resistant to gentamicin. This information has been useful in the selection of antibiotics for the treatment of enterococcal endocarditis wherein cure rates may correlate with the use of synergistic combinations (15) .
Other combinations of antibiotics which effect bacterial cell wall synthesis, such as cycloserine, bacitracin, vancomycin, cephalothin, methicillin, oxacillin, and ampicillin, have been shown to have a synergistic effect in combination with streptomycin against many strains of enterococci (9, 13). Vancomycin and gentamicin has been shown to be effective against more strains of enterococci than vancomycin and streptomycin (14). Carbenicillin and gentamicin has been shown to be synergistic against enterococci as well (7). Since the combination of oxacillin and gentamicin might be used as emperic therapy or in mixed infections, its activity against enterococci is of interest. This combination was recently reported to be synergistic against 3/14 strains of enterococci using different criteria of synergy (time killing curves) than those used in this study (checkerboard technique) (4) . In that study, nafcillin and gentamicin were more effective than oxacillin and gentamicin against enterococci.
MATERIALS AND METHODS Enterococci. Thirty-four strains of enterococci isolated from a variety of sites in different patients were obtained from the clinical microbiology laboratory at the Yale-New Haven Hospital. All strains were identified by the usual growth criteria (2). They were gram-positive cocci producing nonhemolytic or y-hemolytic colonies on sheep blood agar. They grew in both 6.5% NaCl broth and bile esculin agar and hydrolized sodium hippurate. Serologic testing was not done.
Antibiotics. Sodium oxacillin standard powder was supplied by Bristol Laboratories, Syracuse, N.Y. Gentamicin sulfate laboratory standard was supplied by Schering Corporation, Bloomfield, N.J. Synergy studies. A checkerboard technique was employed as previously reported (1). The final concentrations of oxacillin ranged from 500 to 0.25 ,ug/ml, and gentamicin ranged from 12 to 0.19 ,ug/ml. The minimal inhibitory concentration (MIC) was defined as the lowest concentration of one drug that prevented gross turbidity upon visual inspection after overnight incubation at 37 C. From the clear wells, approximately 10 ,ul of broth was removed and subcultured on sheep blood agar. The minimal bactericidal concentration (MBC) was designated as the lowest concentration of one drug that prevented growth on subculture. All studies were conducted in triplicate and repeated if necessary until a majority of assays were in agreement for any one strain. A reduction of the MIC or MBC of both antibiotics by fourfold was defined as synergy, whereas a similar reduction of one antibiotic and a twofold reduction of the MIC or MBC of the other antibiotic was defined as partial synergy. Indifference was defined as a twofold reduction in the MIC or MBC of only one antibiotic and antagonism as no reduction or an increase in the MIC or MBC of either antibiotic. When the MIC or MBC of gentamicin exceeded 12 ,ug/ml (the highest concentration on the microtiter plate), quadruplicate determinations of the MIC and MBC were made using gentamicin concentrations ranging from 0.10 to 192 ,ug/ml. RESULTS MIC and MBC of oxacillin and gentamicin. The cumulative percentage of strains killed hibited (MIC) or killed (MBC) by oxacillin and gentamicin used alone is summarized in Fig. 1 . The MBCs of oxacillin and gentamicin for these strains ranged from 16 to 250 ,g/ml (median 32 ,ug/ml) for oxacillin and 12 to 48 ,ug/ml (median 24 ,ug/ml) for gentamicin.
MBC of oxacillin in presence of gentamicin. The cumulative pecentage of strains killed by oxacillin in the presence of varying amounts of gentamicin is summarized in Fig. 2 . The MBC of oxacillin for 50% of strains in the presence of 12, 6, 3, and 1.5 ,ug of gentamicin per ml, respectively, was 2, 8, 16, and 32 ,ug/ml. At these same concentrations of gentamicin, respectively, 100% of strains were killed by 16, 32, and 64 gg/ml. against 27/34 (80%) of strains tested using the more strict criteria and against 7/34 (20%) using the less strict criteria (see above). In four instances, the degree of synergism was striking with MBCs of each antibiotic reduced by eightfold (12% MBC) or more. MIC data were comparable. There is no correlation between the degree of synergy and the MIC or MBC of either antibiotic. An example of an isobologram demonstrating the synergism of this combination is shown in Fig. 4 . DISCUSSION The selection of any combination of antibiotics to be used as emperic therapy depends on the probability that the likely organism(s) causing the infection is inhibited or killed by the combination. Hence, we analyzed the susceptibility of enterococci to various combinations of oxacillin and gentamicin in terms of frequency distribution. When 
